These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7543348)

  • 21. Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis.
    Blackburn WD; Heck LW; Loose LD; Eskra JD; Carty TJ
    Arthritis Rheum; 1991 Feb; 34(2):204-10. PubMed ID: 1847289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis.
    Weisman MH
    Clin Ther; 1986; 8(4):427-38. PubMed ID: 3524843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Tenidap (CP-66,248) on human neutrophil arachidonic acid metabolism, chemotactic potential and clinical efficacy in the treatment of rheumatoid arthritis.
    Smith DM; Johnson JA; Loeser R; Turner RA
    Agents Actions; 1990 Aug; 31(1-2):102-9. PubMed ID: 2126672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental AA-amyloidosis in mice is inhibited by treatment with the anti-rheumatic drug tenidap.
    Husebekk A; Stenstad T
    Scand J Immunol; 1996 May; 43(5):551-5. PubMed ID: 8633214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
    Bianchi Porro G; Montrone F; Lazzaroni M; Manzionna G; Caruso I
    Ital J Gastroenterol Hepatol; 1999; 31(5):378-85. PubMed ID: 10470596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis.
    Perez-Ruiz F; Alonso-Ruiz A; Ansoleaga JJ
    Clin Rheumatol; 1996 Sep; 15(5):473-7. PubMed ID: 8894360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of etodolac and diclofenac in patients with rheumatoid arthritis.
    Lonauer G; Tisscher JR; Lim HG; Bijlsma JW
    Curr Med Res Opin; 1993; 13(2):70-7. PubMed ID: 8325044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two double blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritis.
    Kolodny AL
    J Rheumatol; 1988 Aug; 15(8):1205-11. PubMed ID: 3054094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.
    Pareek A; Chandanwale AS; Oak J; Jain UK; Kapoor S
    Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aceclofenac in rheumatoid arthritis: a useful and novel anti-inflammatory.
    Hunter JA; Parnham MJ; Balaguer XG
    Clin Rheumatol; 1996 Jul; 15(4):329-34. PubMed ID: 8853164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ;
    J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of tenidap on the anti-hypertensive efficacy of ACE inhibitors in patients treated for mild to moderate hypertension.
    Rapeport WG; Grimwood VC; Hosie J; Sloan PM; Korlipara K; Silvert BD; James I; Mechie GL; Anderton JL
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):57S-61S. PubMed ID: 7547097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial.
    Kellner HL; Li C; Essex MN
    Curr Med Res Opin; 2012 Sep; 28(9):1537-45. PubMed ID: 22852870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L;
    Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein as an index of disease activity. Comparison of tenidap, cyclophosphamide and dexamethasone in rat adjuvant arthritis.
    Otterness IG; Pazoles PP; Moore PF; Pepys MB
    J Rheumatol; 1991 Apr; 18(4):505-11. PubMed ID: 2066940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenidap.
    Madhok R
    Lancet; 1995 Aug; 346(8973):481-5. PubMed ID: 7637484
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of photosensitising potential of tenidap, a novel anti-rheumatic agent.
    Ferguson J; Leeming MR
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):63S-66S. PubMed ID: 7547098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.